Immune checkpoint pathway is the focus of current cancer research, and one of the best-characterized checkpoint proteins is PD-1. T-cell activation is suppressed by the binding that occurs between ...
October 18 th, 2021, saw Innovent reveal that the combination of TYVYT ® Sintilimab injection, Avastin ® Bevacizumab injection and chemotherapy in patients with EGFR-mutated non-squamous, non-small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback